Medically important bacterial-fungal interactions
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Whether it is in the setting of disease or in a healthy state, the human body contains a diverse range of microorganisms, including bacteria and fungi. The interactions between these taxonomically diverse microorganisms are highly dynamic and dependent on a multitude of microorganism and host factors. Human disease can develop from an imbalance between commensal bacteria and fungi or from invasion of particular host niches by opportunistic bacterial and fungal pathogens. This Review describes the clinical and molecular characteristics of bacterial-fungal interactions that are relevant to human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, numerous studies have shown that many bacteria inhibit C. albicans filamentation [13,14].”
From Mitochondrial Activity and Cyr1 Are Key Regulators of Ras1 Activation of C. albicans Virulence Pathways (2015) · cites this paper as [13]
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Self-citationThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687 · cited 1×
“The implications of these findings are broad and lend support to the 'hygiene hypothesis', whereby an increase in atopic disease in the developed world, mediated by an increase in T H 2 cell responses, is related to a more hygienic environment in which there is less bacterial stimulatio”
ResultAn increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age Children
Braun-Fahrländer, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., Maisch, S., Carr, D., Gerlach, F., Bufe, A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020057 · Cited by 1,811
Nonfilamentous C. albicans Mutants Are Avirulent
Lo, H.-J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A., & Fink, G. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80358-x · Cited by 1,809
Fleming, A. (1929) · PubMed Central · Cited by 1,647
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055 · cited 1×
“1 ), where mixed bacterial–fungal biofilms are commonly foun”
BackgroundQuorum Sensing in the Dimorphic Fungus Candida albicans Is Mediated by Farnesol
Hornby, J. M., Jensen, E. C., Lisec, A. D., Tasto, J. J., Jahnke, B., Shoemaker, R., Dussault, P., & Nickerson, K. W. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.7.2982-2992.2001 · Cited by 983 · cited 1×
“albicans populations secrete a quorum-sensing molecule called farnesol, which represses hyphal growth despite cues that normally trigger filamentation, such as serum and 37 °C temperature”
Background
Cited by
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
“rarely colonize human skin but can cause clinical infection especially in conditions of immune deficiency, diabetes or infection following antibiotic us”
BackgroundTopographic diversity of fungal and bacterial communities in human skin
NIH Intramural Sequencing Center Comparative Sequencing Program, Findley, K., Oh, J., Yang, J., Conlan, S., Deming, C., Meyer, J. A., Schoenfeld, D., Nomicos, E., Park, M., et al. (2013) · Nature · doi:10.1038/nature12171 · Cited by 1,206
Temporal Stability of the Human Skin Microbiome
Oh, J., Byrd, A. L., Park, M., Kong, H. H., & Segre, J. A. (2016) · Cell · doi:10.1016/j.cell.2016.04.008 · Cited by 1,036
“Observing interkingdom dynamics is meaningful since these interactions may exacerbate disease severity (Peleg et al., 2010) or facilitate transitions from opportunistic to pathogenic.”
Frey-Klett, P., Burlinson, P., Deveau, A., Barret, M., Tarkka, M., & Sarniguet, A. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-11 · Cited by 913
“Coinfection by these pathogens is considered to worsen lung function relative to infection by each pathogen alone (265, 301).”
BackgroundEssential Oils and Antifungal Activity
Nazzaro, F., Fratianni, F., Coppola, R., & Feo, V. D. (2017) · Pharmaceuticals · doi:10.3390/ph10040086 · Cited by 817
“It inhibits biofilm formation when provided early during adherence [126].”
BackgroundBacterial–fungal interactions: ecology, mechanisms and challenges
Deveau, A., Bonito, G., Uehling, J., Paoletti, M., Becker, M., Bindschedler, S., Hacquard, S., Hervé, V., Labbé, J., Lastovetsky, O. A., et al. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy008 · Cited by 794
Enaud, R., Prevel, R., Ciarlo, E., Beaufils, F., Wieërs, G., Guery, B., & Delhaes, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00009 · Cited by 738
“Although often dichotomized due to technical and analysis sequencing issues, critical interactions exist between bacteriobiota and mycobiota (Peleg et al., 2010).”
BackgroundDialogue between skin microbiota and immunity
Belkaid, Y., & Segre, J. A. (2014) · Science · doi:10.1126/science.1260144 · Cited by 749
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
“Given that immunocompromised individuals 388 are highly susceptible to infections and are faced with many additional medical risk 389 factors, it is difficult to assess the extent of these polymicrobial interactions on the 390 clinical prognosis of patients [49], and even more difficult to deduce molecular 391 mechani…”
BackgroundMechanisms and implications of bacterial–fungal competition for soil resources
Wang, C., & Kuzyakov, Y. (2024) · The ISME Journal · doi:10.1093/ismejo/wrae073 · Cited by 693
“Biofilms increase competitiveness by accumulating antagonist molecules duetotheslowoutwarddiffusionofcompounds[92].”
BackgroundPolymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
“modulation, or a combination of these events (162).”
BackgroundGut microbiome-host interactions in health and disease
Kinross, J. M., Darzi, A. W., & Nicholson, J. K. (2011) · Genome Medicine · doi:10.1186/gm228 · Cited by 691
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612
Falsetta, M. L., Klein, M. I., Colonne, P. M., Scott-Anne, K., Gregoire, S., Pai, C.-H., Gonzalez-Begne, M., Watson, G., Krysan, D. J., Bowen, W. H., et al. (2014) · Infection and Immunity · doi:10.1128/iai.00087-14 · Cited by 561
The emerging world of the fungal microbiome
Huffnagle, G. B., & Noverr, M. C. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.04.002 · Cited by 567
“) and indirect activity on the host response are mechanisms by which Candida and other fungi interact with bacteria in the microbiome to regulate fungal levels and host responses to fungal colonization [23].”
BackgroundThreats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture
Fisher, M. C., Gurr, S. J., Cuomo, C. A., Blehert, D. S., Jin, H., Stukenbrock, E. H., Stajich, J. E., Kahmann, R., Boone, C., Denning, D. W., et al. (2020) · mBio · doi:10.1128/mbio.00449-20 · Cited by 536
Structure and function of the human skin microbiome
Schommer, N. N., & Gallo, R. L. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.10.001 · Cited by 532
“One explanation of communication between bacteria and fungi is based on quorum sensing systems [80, 81].”
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Narunsky-Haziza, L., Sepich-Poore, G. D., Livyatan, I., Asraf, O., Martino, C., Nejman, D., Gavert, N., Stajich, J. E., Amit, G., González, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.005 · Cited by 538
“Intratumoral mycobiome-bacteriome-immunome interactions Fungi interact with bacteria by physical and biochemical mechanisms (Peleg et al., 2010), motivating exploration of interdomain connections between mycobiome and bacteriome data in WIS and TCGA cohorts (Nejman et al.”
BackgroundN-Acetylglucosamine Functions in Cell Signaling
Konopka, J. B. (2012) · Scientifica · doi:10.6064/2012/489208 · Cited by 414
“In recent years there has been growing awareness that chemical messengers are not only used to communicate in an intraspecies fashion, they can also act between species [111–113].”
BackgroundRichard, M. L., & Sokol, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0121-2 · Cited by 406
Zhang, F., Aschenbrenner, D., Yoo, J. Y., & Zuo, T. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00203-8 · Cited by 388
Microbial interactions: ecology in a molecular perspective
Braga, R. M., Dourado, M. N., & Araújo, W. L. (2016) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2016.10.005 · Cited by 368
Polarization of microbial communities between competitive and cooperative metabolism
Machado, D., Maistrenko, O. M., Andrejev, S., Kim, Y., Bork, P., Patil, K. R., & Patil, K. R. (2021) · Nature Ecology & Evolution · doi:10.1038/s41559-020-01353-4 · Cited by 351
The Type VI secretion system: a versatile bacterial weapon
Coulthurst, S. (2019) · Microbiology · doi:10.1099/mic.0.000789 · Cited by 346
“It is clear from the studies described in the previous section that the bacterial T6SS is able to deploy effector proteins against eukaryotic cells, and it is also generally appreciated that many polymicrobial communities, including those relevant clinically, contain both bacteria and fungi [111].”
BackgroundMukherjee, P. K., Chandra, J., Retuerto, M., Sikaroodi, M., Brown, R. E., Jurevic, R., Salata, R. A., Lederman, M. M., Gillevet, P. M., & Ghannoum, M. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003996 · Cited by 337
Durack, J., Lynch, S. V., Nariya, S., Bhakta, N. R., Beigelman, A., Castro, M., Dyer, A.-M., Israel, E., Kraft, M., Martin, R. J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.055 · Cited by 320
“Subjects with insufficient 16S rRNA amplicons for microbiota profiling were younger (median, 28 [22-37] vs 34 [25-44] years; P 5 .”
Kalia, N., Singh, J., & Kaur, M. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-0347-4 · Cited by 275
Schlecht, L. M., Peters, B. M., Krom, B. P., Freiberg, J. A., Hänsch, G. M., Filler, S. G., Jabra-Rizk, M. A., & Shirtliff, M. E. (2015) · Microbiology · doi:10.1099/mic.0.083485-0 · Cited by 281
“Yet, despite the gravity of such infections, areas of study in polymicrobial diseases and particularly those involving vastly diverse pathogens such as fungi and bacteria are in their infancy (Peleg et al., 2010; Shirtliff et al., 2009).”
Forgotten fungi—the gut mycobiome in human health and disease
Huseyin, C. E., O’Toole, P. W., Cotter, P. D., & Scanlan, P. D. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw047 · Cited by 278
Advances in the microbial etiology and pathogenesis of early childhood caries
Hajishengallis, E., Parsaei, Y., Klein, M. I., & Koo, H. (2017) · Molecular Oral Microbiology · doi:10.1111/omi.12152 · Cited by 261
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
“Clinical and experimental data underscore the significance of these interactions, as explained in several excellent recent reviews (Morales and Hogan 2010; Peleg et al. 2010, 2012a; Harriott and Noverr 2011).”
BackgroundControl of Candida albicans Metabolism and Biofilm Formation by Pseudomonas aeruginosa Phenazines
Morales, D. K., Grahl, N., Okegbe, C., Dietrich, L. E. P., Jacobs, N. J., & Hogan, D. A. (2013) · mBio · doi:10.1128/mbio.00526-12 · Cited by 242
Self-citationGraham, C. E., Cruz, M. R., Garsin, D. A., & Lorenz, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620432114 · Cited by 239
Fungal Biofilms and Polymicrobial Diseases
Costa-Orlandi, C., Sardi, J., Pitangui, N., De Oliveira, H., Scorzoni, L., Galeane, M., Medina-Alarcón, K., Melo, W., Marcelino, M., Braz, J., et al. (2017) · Journal of Fungi · doi:10.3390/jof3020022 · Cited by 231
Sztajer, H., Szafranski, S. P., Tomasch, J., Reck, M., Nimtz, M., Rohde, M., & Wagner-Döbler, I. (2014) · The ISME Journal · doi:10.1038/ismej.2014.73 · Cited by 236
“Polymicrobial pathogenic biofilms are not only found in the oral cavity, but also in the respiratory tracts, skin, the reproductive and urinary tract, in patients with chronic lung diseases and on in-dwelling mechanical devices (Peleg et al., 2010).”
BackgroundThe type VI secretion system deploys antifungal effectors against microbial competitors
Trunk, K., Peltier, J., Liu, Y.-C., Dill, B. D., Walker, L., Gow, N. A. R., Stark, M. J. R., Quinn, J., Strahl, H., Trost, M., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0191-x · Cited by 237
Fungal-Bacterial Interactions in Health and Disease
Krüger, W., Vielreicher, S., Kapitan, M., Jacobsen, I., & Niemiec, M. (2019) · Pathogens · doi:10.3390/pathogens8020070 · Cited by 227
Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice
Jain, U., Ver Heul, A. M., Xiong, S., Gregory, M. H., Demers, E. G., Kern, J. T., Lai, C.-W., Muegge, B. D., Barisas, D. A. G., Leal-Ekman, J. S., et al. (2021) · Science · doi:10.1126/science.abd0919 · Cited by 218
Self-citationTrained immunity: adaptation within innate immune mechanisms
Domínguez-Andrés, J., dos Santos, J. C., Bekkering, S., Mulder, W. J. M., van der Meer, J. W. M., Riksen, N. P., Joosten, L. A. B., & Netea, M. G. (2023) · Physiological Reviews · doi:10.1152/physrev.00031.2021 · Cited by 205
Hwang, G., Liu, Y., Kim, D., Li, Y., Krysan, D. J., & Koo, H. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006407 · Cited by 214
Kean, R., Rajendran, R., Haggarty, J., Townsend, E. M., Short, B., Burgess, K. E., Lang, S., Millington, O., Mackay, W. G., Williams, C., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00258 · Cited by 195
“Advancement in biofilm research has highlighted that these cellular communities are rarely composed of a single-species consortia, but instead exist as complex, diverse, and heterogeneous structures (Peleg et al., 2010).”
BackgroundMucosal biofilms of Candida albicans
Ganguly, S., & Mitchell, A. P. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.001 · Cited by 200
The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective
Suhr, M. J., & Hallen-Adams, H. E. (2015) · Mycologia · doi:10.3852/15-147 · Cited by 200
“Bacteria and fungi indisputably interact physically and chemically with one another within an ecosystem (Peleg et al. 2010).”
BackgroundDysbiosis of Fungal Microbiota in the Intestinal Mucosa of Patients with Colorectal Adenomas
Luan, C., Xie, L., Yang, X., Miao, H., Lv, N., Zhang, R., Xiao, X., Hu, Y., Liu, Y., Wu, N., et al. (2015) · Scientific Reports · doi:10.1038/srep07980 · Cited by 190
Gregoire, S., Xiao, J., Silva, B. B., Gonzalez, I., Agidi, P. S., Klein, M. I., Ambatipudi, K. S., Rosalen, P. L., Bauserman, R., Waugh, R. E., et al. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05203-11 · Cited by 191
“GtfB may represent an additional class of bacterium-derived products other than quorum-sensing molecules (3, 46) that could directly influence biofilm formation by both of these species (from two distinct kingdoms) by modulating: (i) the initial interaction between S.”
BackgroundInfluentialEnterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans
Cruz, M. R., Graham, C. E., Gagliano, B. C., Lorenz, M. C., & Garsin, D. A. (2013) · Infection and Immunity · doi:10.1128/iai.00914-12 · Cited by 188
The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases
Bradford, L. L., & Ravel, J. (2017) · Virulence · doi:10.1080/21505594.2016.1237332 · Cited by 191
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in Applied Microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 184
Li, H., Goh, B. N., Teh, W. K., Jiang, Z., Goh, J. P. Z., Goh, A., Wu, G., Hoon, S. S., Raida, M., Camattari, A., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.11.034 · Cited by 188
Streptomyces exploration is triggered by fungal interactions and volatile signals
Jones, S. E., Ho, L., Rees, C. A., Hill, J. E., Nodwell, J. R., & Elliot, M. A. (2017) · eLife · doi:10.7554/elife.21738 · Cited by 189
“Microbial behavior is now known to be modulated by neighbouring organisms, where interspecies interactions can have profound and diverse consequences, including modifying virulence of human pathogens (Peleg et al., 2010), altering antibiotic resistance profiles of mixed-species biofilms (Oliveira et al.”
BackgroundCopsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis
Essig, A., Hofmann, D., Münch, D., Gayathri, S., Künzler, M., Kallio, P. T., Sahl, H.-G., Wider, G., Schneider, T., & Aebi, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.599878 · Cited by 179
“aeruginosa were selected as competitors, which are well characterized and are known to interact with fungi (1, 32, 33).”
BackgroundTritagonist as a new term for uncharacterised microorganisms in environmental systems
Freimoser, F. M., Pelludat, C., & Remus-Emsermann, M. N. P. (2016) · The ISME Journal · doi:10.1038/ismej.2015.92 · Cited by 172
“…kind of interspecific interaction that may for example be mediated by the following: direct physical interaction, exchange of signalling molecules, nutrient competition, metabolising of by-products, environmental changes (for example, pH) or modulation of host-immune responses (Peleg et al., 2010).”
BackgroundCross-Domain and Viral Interactions in the Microbiome
Rowan-Nash, A. D., Korry, B. J., Mylonakis, E., & Belenky, P. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00044-18 · Cited by 163
Self-citationSoil-on-a-Chip: microfluidic platforms for environmental organismal studies
Stanley, C. E., Großmann, G., Solvas, X. C. I., & deMello, A. J. (2015) · Lab on a Chip · doi:10.1039/c5lc01285f · Cited by 161
Candida–streptococcal interactions in biofilm-associated oral diseases
Koo, H., Andes, D. R., & Krysan, D. J. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007342 · Cited by 175
Willger, S. D., Grim, S. L., Dolben, E. L., Shipunova, A., Hampton, T. H., Morrison, H. G., Filkins, L., O’Toole, G. A., Moulton, L. A., Ashare, A., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-40 · Cited by 179
“albicans in ~40%–75% CF subjects [8-21] and described its association with reduced lung function [16,22].”
BackgroundSelf-citationMycobiome in the Gut: A Multiperspective Review
Chin, V. K., Yong, P. V. C., Chong, P. P., Nordin, S. A., Basir, R., & Abdullah, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/9560684 · Cited by 178
“albicans, can also modify quorum sensing regulation in Pseudomonas aeruginosa [99, 100].”
BackgroundBriard, B., Heddergott, C., & Latgé, J.-P. (2016) · mBio · doi:10.1128/mbio.00219-16 · Cited by 153
Morales, D. K., Jacobs, N. J., Rajamani, S., Krishnamurthy, M., Cubillos‐Ruiz, J. R., & Hogan, D. A. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07414.x · Cited by 158
“It has been demonstrated that in mixed-species biofilms containing bacteria and fungi, a range of different interactions can occur, including increased resistance to antimicrobials, enhanced surface colonization and interspecies antagonism (Shirtliff et al., 2009; Morales and Hogan, 2010; Peleg et al., 2010).”
BackgroundSelf-citationSeelbinder, B., Chen, J., Brunke, S., Vazquez-Uribe, R., Santhaman, R., Meyer, A.-C., Lino, F. S. D. O., Chan, K., Loos, D., Imamovic, L., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00899-6 · Cited by 165
Molecular Bacteria-Fungi Interactions: Effects on Environment, Food, and Medicine
Scherlach, K., Graupner, K., & Hertweck, C. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155702 · Cited by 153
The significance of Candida in the human respiratory tract: our evolving understanding
Pendleton, K. M., Huffnagle, G. B., & Dickson, R. P. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx029 · Cited by 154
Kim, D., Liu, Y., Benhamou, R. I., Sánchez, H., Simón‐Soro, Á., Li, Y. H., Hwang, G., Fridman, M., Andes, D. R., & Koo, H. (2018) · The ISME Journal · doi:10.1038/s41396-018-0113-1 · Cited by 145
“or antifungal agents despite the polymicrobial nature of disease-causing biofilms [6, 7].”
BackgroundMantravadi, P. K., Kalesh, K., Dobson, R. C. J., Hudson, A. O., & Parthasarathy, A. (2019) · Antibiotics · doi:10.3390/antibiotics8010008 · Cited by 161
“The lungs of immuno-compromised individuals are often the sites of bacterial-fungal “superinfections”, notably involving Pseudomonas aeruginosa and fungi, such as Candida albicans and Aspergillus fumigatus, which may worsen lung function [227,230].”
BackgroundBacterial–fungal interactions revealed by genome-wide analysis of bacterial mutant fitness
Pierce, E. C., Morin, M., Little, J., Liu, R. B., Tannous, J., Keller, N. P., Pogliano, K., Wolfe, B. E., Sanchez, L. M., & Dutton, R. J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00800-z · Cited by 158
Current Trends and Potential Applications of Microbial Interactions for Human Welfare
Tshikantwa, T. S., Ullah, M. W., He, F., & Yang, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01156 · Cited by 156
“, bacteria-fungi infections) in humans is also crucial in that the consequences of such infections can vary from those caused by individual mono-species (Peleg et al., 2010).”
BackgroundQiu, X., Zhang, F., Yang, X., Wu, N., Jiang, W., Li, X., Li, X., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep10416 · Cited by 151
Review article: fungal microbiota and digestive diseases
Wang, Z., Yang, Y., Stefka, A. T., Sun, G., & Peng, L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12665 · Cited by 149
“complex and species dependent, and have dramatic effects on the growth and pathogenesis of microbes.(4) Evidence from human epidemiological and animal studies implicates mycotoxins, generated as fungal metabolites, in GI and liver cancer development and in other chronic GI disorders.”
BackgroundTrejo-Hernández, A., Andrade-Domínguez, A., Hernández, M., & Encarnación, S. (2014) · The ISME Journal · doi:10.1038/ismej.2014.53 · Cited by 135
“For example, biofilm bacteria are more resistant to killing by antibiotics, biocides and host defenses than planktonic cells and may be less vulnerable to predators (Peleg et al., 2010).”
BackgroundRole of Short Chain Fatty Acids in Controlling Tregs and Immunopathology During Mucosal Infection
Bhaskaran, N., Quigley, C., Paw, C., Butala, S., Schneider, E., & Pandiyan, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01995 · Cited by 144
Joyner, P. M., Liu, J., Zhang, Z., Merritt, J. L., Qi, F., & Cichewicz, R. H. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00579g · Cited by 132
Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development
Chen, Q., Yang, Z., Liu, H., Man, J., Oladejo, A. O., Ibrahim, S., Wang, S., & Hao, B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050674 · Cited by 152
“In addition to the noted interactions, there are specific associations between fungi and bacteria [143] such as, Streptococcus adhering to Candida albicans through cell surface polysaccharide receptors and peptide adhesins and peptide adhesins.”
BackgroundIshijima, S. A., Hayama, K., Burton, J. P., Reid, G., Okada, M., Matsushita, Y., & Abe, S. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07055-11 · Cited by 131
Biotic Interactions Shape the Ecological Distributions of Staphylococcus Species
Kastman, E. K., Kamelamela, N., Norville, J. W., Cosetta, C. M., Dutton, R. J., & Wolfe, B. E. (2016) · mBio · doi:10.1128/mbio.01157-16 · Cited by 127
Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome
Cabral, D. J., Penumutchu, S., Reinhart, E. M., Zhang, C., Korry, B. J., Wurster, J. I., Nilson, R., Guang, A., Sano, W. H., Rowan-Nash, A. D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.020 · Cited by 141
“This disruption, broadly referred to as dysbiosis, can lead to decreased colonization resistance against various fungal and bacterial pathogens, leading to a number of opportunistic infections (Blaser, 2011; Mukherjee et al., 2014; Peleg et al., 2010; Preidis and Versalovic, 2009; Rafii et al., 2008).”
BackgroundImpact of Bacterial–Fungal Interactions on the Colonization of the Endosphere
van Overbeek, L. S., & Saikkonen, K. (2016) · Trends in Plant Science · doi:10.1016/j.tplants.2016.01.003 · Cited by 131
“Candida albicans is a filamentous yeast that produces farnesol for communication between the yeast and filamentous forms, and the yeast form is more resistant to the antibiotic pyocyanin produced by Pseudomonas aeruginosa [41,42].”
BackgroundBoix-Amorós, A., Puente‐Sánchez, F., du Toit, E., Linderborg, K. M., Zhang, Y., Yang, B., Salminen, S., Isolauri, E., Tamames, J., Mira, Á., et al. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.02994-18 · Cited by 129
Cugini, C., Morales, D. K., & Hogan, D. A. (2010) · Microbiology · doi:10.1099/mic.0.037911-0 · Cited by 135
“, 2009) and interspecies (Peleg et al., 2010; Shirtliff et al., 2009b) interactions.”
Self-citationCandida –Bacteria Interactions: Their Impact on Human Disease
Allison, D. L., Willems, H. M. E., Jayatilake, J. A. M. S., Bruno, V. M., Peters, B. M., & Shirtliff, M. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0030-2016 · Cited by 131
“Currently, fungal-bacterial relations have gained attention due to their impact on human health, the environment, and the health care economy (8).”
BackgroundPolymicrobial wound infections: Pathophysiology and current therapeutic approaches
Bertesteanu, S. V., Triaridis, S., Stankovic, M. D., Lazăr, V., Chifiriuc, M. C., Vlad, M., & Grigore, R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.012 · Cited by 122
Fan, X.-Y., Gao, J., Pan, K.-L., Li, D., Dai, H., & Li, X. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.05.004 · Cited by 116
Grahl, N., Demers, E. G., Lindsay, A. K., Harty, C. E., Willger, S. D., Piispanen, A. E., & Hogan, D. A. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005133 · Cited by 111
Self-citationKoo, H., & Bowen, W. H. (2014) · Future Microbiology · doi:10.2217/fmb.14.92 · Cited by 110
The role of Lactobacillus species in the control of Candida via biotrophic interactions
Zangl, I., Pap, I.-J., Aspöck, C., & Schüller, C. (2020) · Microbial Cell · doi:10.15698/mic2020.01.702 · Cited by 123
Streptococcus mutans Can Modulate Biofilm Formation and Attenuate the Virulence of Candida albicans
Barbosa, J. O., Rossoni, R. D., Vilela, S. F. G., de Alvarenga, J. A., Velloso, M. D. S., Prata, M. C. D. A., Jorge, A. O. C., & Junqueira, J. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150457 · Cited by 108
“Studies have shown that bacteria and fungi present in biofilms can influence each other through the secretion of extracellular signaling molecules or physical interactions of cell-cell contact or aggregation [4].”
BackgroundTherapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections
Batoni, G., Maisetta, G., & Esin, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020482 · Cited by 104
Melo, W., Celiešiūtė-Germanienė, R., Šimonis, P., & Stirkė, A. (2021) · Virulence · doi:10.1080/21505594.2021.1960105 · Cited by 106
Microbial Colonization From the Fetus to Early Childhood—A Comprehensive Review
Senn, V., Bassler, D., Choudhury, R. A., Scholkmann, F., Righini‐Grunder, F., Vuille-dit-Bille, R. N., & Restin, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.573735 · Cited by 107
“The aim is to protect this delicate balance of bacterial and probably fungal interactions which support the healthy GITmicrobiota (Peleg et al., 2010).”
BackgroundBeaussart, A., Herman, P., El-Kirat-Chatel, S., Lipke, P. N., Kucharíková, S., Van Dijck, P., & Dufrêne, Y. F. (2013) · Nanoscale · doi:10.1039/c3nr03272h · Cited by 95
Zheng, H., Kim, J., Liew, M., Yan, J. K., Herrera, O., Bok, J. W., Kelleher, N. L., Keller, N. P., & Wang, Y. (2014) · Current Biology · doi:10.1016/j.cub.2014.11.018 · Cited by 107
“fumigatus worsen more than those infected by each organism alone [1, 2].”
BackgroundInfluentialBergeron, A. C., Seman, B. G., Hammond, J. H., Archambault, L. S., Hogan, D. A., & Wheeler, R. T. (2017) · Infection and Immunity · doi:10.1128/iai.00475-17 · Cited by 97
Self-citationVirulence and pathogenicity ofCandida albicansis enhanced in biofilms containing oral bacteria
Cavalcanti, Y. W., Morse, D. J., da Silva, W. J., Cury, A. A. D. B., Wei, X., Wilson, M. J., Milward, P. J., Lewis, M. A. O., Bradshaw, D. J., & Williams, D. W. (2015) · Biofouling · doi:10.1080/08927014.2014.996143 · Cited by 107
“The effect could be due to several factors, eg alteration of environmental parameters including nutrient limitation, hypoxia, or specific effects such as inhibition of the farnesol pathway of hyphal suppression (Morales & Hogan 2010; Peleg et al. 2010; Gow et al. 2011; Lu et al. 2013; Buu & Chen 2014).”
BackgroundInfluentialPalková, Z., & Váchová, L. (. (2012) · Springer eBooks · doi:10.1007/978-94-007-4264-2 · Cited by 94
The mammalian mycobiome: A complex system in a dynamic relationship with the host
Lai, G. C., Tan, T. G., & Pavelka, N. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1438 · Cited by 98
Li, Y., Wang, K., Zhang, B., Tu, Q., Yao, Y., Cui, B., Ren, B., He, J., Shen, X., Nostrand, J. D. V., et al. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0045-2 · Cited by 101
Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis
Kaźmierczak-Siedlecka, K., Dvořák, A., Folwarski, M., Daca, A., Przewłócka, K., & Makarewicz, W. (2020) · Cancers · doi:10.3390/cancers12051326 · Cited by 99
Peterfreund, G. L., Vandivier, L. E., Sinha, R., Marozsan, A. J., Olson, W. C., Zhu, J., & Bushman, F. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046966 · Cited by 89
“Furthermore, there are many established interactions between specific fungi and potential pathogens leading to enhanced virulence [45].”
BackgroundTan, C. T., Xu, X., Qiao, Y., & Wang, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-22845-2 · Cited by 108
Antifungal Activity of Microbial Secondary Metabolites
Coleman, J. J., Ghosh, S., Okoli, I. G., & Mylonakis, E. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025321 · Cited by 97
“Additionally, the inhibitory activity of gliotoxin against pathogenic bacteria suggests this compound may also have a role in the interaction between medicallyrelevant bacteria and fungi capable of synthesizing the compound, as these interactions may occur more frequently [42,43].”
BackgroundSelf-citation
Metadata
- Authors
- Peleg, A. Y., Hogan, D. A., & Mylonakis, E.
- Affiliations
- Harvard University (US)
- Dartmouth College (US)
- Venue
- Nature Reviews Microbiology
- Published
- 2010-03-29
- Volume
- 8
- Issue
- 5
- Pages
- 340-349
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2012508946
- Cited by
- 619
- References
- 95
- Citations by year
- 2026: 34 · 2025: 37 · 2024: 41 · 2023: 58 · 2022: 48 · 2021: 54 · 2020: 61 · 2019: 46 · 2018: 34 · 2017: 35 · 2016: 48 · 2015: 34 · 2014: 30 · 2013: 25 · 2012: 18
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- fungal-bacterial interactions, commensal microorganisms, opportunistic pathogens, dysbiosis, host-microbe interactions, fungal pathogens, pathogenic bacteria, human disease
- MeSH terms
- Acinetobacter, Animals, Bacteria, Bacterial Infections, Candida albicans, Cryptococcus neoformans, Disease Models, Animal, Fungi, Humans, Models, Biological, Mycoses, Pseudomonas, Staphylococcus, Streptococcus, Virulence, Bacterial Physiological Phenomena, Host-Pathogen Interactions, Metagenome, Microbial Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.